MusB Research

New Research from USF Center for Microbiome Research

Gut Microbiota, Leaky Gut & Metabolic Disorders: The Hidden Cascade

We’re excited to share our latest review article published in Current Obesity Reports (2025):
“A Cascade of Microbiota-Leaky Gut-Inflammation—Is it a Key Player in Metabolic Disorders?”
Authored by Dr. Sidharth Mishra, Bryan Agadzi, Dr. Shalini Jain, and Dr. Hariom Yadav
🔗 Read the article

This comprehensive review was led by Dr. Yadav’s lab at the USF Center for Microbiome Research, and it explores how gut microbiota disturbances trigger a leaky gut, driving inflammation and systemic metabolic dysfunctions like obesity, type 2 diabetes, cardiovascular diseases, and even cognitive decline.


Why Leaky Gut Deserves Your Attention

Leaky gut, or increased intestinal permeability, allows harmful microbial byproducts (like LPS) to seep into the bloodstream. This triggers a condition called metabolic endotoxemia, leading to chronic low-grade inflammation—one of the key contributors to insulin resistance and the pathogenesis of multiple metabolic disorders.

Our review explores how environmental triggers (diet, stress, alcohol, infections) and microbiota imbalances damage the tight junction proteins (ZO-1, OCLN, CLDNs), weakening gut barrier integrity and initiating this destructive cascade.


The Microbiome–Barrier Connection: A Powerful Alliance

A balanced microbiome produces short-chain fatty acids (SCFAs) like butyrate and propionate, as well as anti-inflammatory compounds like indole-3-propionic acid (IPA) and taurine, which support gut lining integrity and immune tolerance.

In metabolic disorders, beneficial bacteria like Faecalibacterium prausnitzii, Bifidobacterium spp., and Akkermansia muciniphila decline—while pro-inflammatory microbes and harmful metabolites like ethanolamine accumulate, directly destabilizing tight junction mRNA via miR-101a activation.


From Gut to Disease: Metabolic, Immune, and Brain Effects

The article highlights the expanding impact of gut barrier dysfunction in:

  • Obesity & Type 2 Diabetes: Elevated LPS, reduced SCFAs, insulin resistance
  • Cardiovascular Disease: Increased IPA and butyrate levels correlate with improved arterial health
  • Neurodegeneration: Microbial toxins crossing the blood-brain barrier
  • IBD & IBS: Tight junction loss and immune overactivation
  • Autoimmune Diseases: Gluten and dysbiosis accelerating leaky gut in celiac and T1DM

Therapeutic Pathways: Modulating the Microbiome

Our review outlines promising strategies to combat leaky gut by restoring microbial balance and metabolic function:

  1. Probiotics: Lactobacillus rhamnosus HL-200, Bifidobacterium, A. muciniphila
  2. Prebiotics: Fructo- and galacto-oligosaccharides (FOS, GOS), acorn, sago
  3. Synbiotics: Combining probiotic strains with targeted prebiotics
  4. Postbiotics: Lipoteichoic acid from heat-killed L. paracasei D3.5 (PoZibio) to enhance barrier integrity
  5. Next-Generation Probiotics (NGPs): F. prausnitzii, R. intestinalis, and others with metabolic and immune benefits
  6. Dietary Interventions: Mediterranean and ketogenic diets, taurine, spermidine, metformin

Systems Biology Meets Gut Health: A New Era

Dr. Yadav’s team emphasizes the power of microbiomics + metabolomics—a systems biology approach to identify precise microbial signatures and functional metabolites (e.g., SCFAs, bile acids, IPA) as biomarkers and therapeutic targets for leaky gut and metabolic diseases.

Future therapies could harness AI, personalized microbiome data, and engineered microbes to repair the gut barrier, rebalance immunity, and prevent chronic disease.


Looking Forward: Toward Precision Gut Health

Our review concludes that restoring gut barrier integrity represents a powerful, underutilized strategy to address widespread chronic conditions. Though challenges remain—including lack of diagnostic clarity, regulatory hurdles, and the need for robust clinical trials—emerging microbiome-targeted therapies offer hope for personalized, preventative care.

We’re proud to contribute this work from the USF Center for Microbiome Research and to advance the dialogue on how the microbiota–leaky gut–inflammation axis influences lifelong health.


We welcome collaboration with clinicians, researchers, startups, and healthcare innovators interested in developing microbiome-based diagnostics and therapeutics.

🔗 Read the article: https://doi.org/10.1007/s13679-025-00624-0

#Microbiome #LeakyGut #MetabolicHealth #Obesity #Diabetes #PrecisionMedicine #Probiotics #SCFA #GutBrainAxis #MicrobiomeResearch #USF #YadavLab #MusBResearch

Postbiotics & Skin Health: New Insights from Our Co-Founders’ Latest Publication

The Global Importance of Postbiotics in Skin Health: A Scientific and Commercial Perspective

The global skincare industry is undergoing a paradigm shift. No longer solely focused on cosmetics and surface-level treatments, dermatological science is diving deeper—into the microscopic world of the skin microbiome. This diverse and complex ecosystem of bacteria, fungi, and viruses inhabits the skin’s surface and layers, playing a pivotal role in maintaining skin integrity, immune responses, and defense against disease. As understanding of this ecosystem has evolved, a new class of therapeutic agents has emerged: postbiotics—non-viable microbial cells or their metabolites that offer powerful benefits without the risks associated with live organisms.

This blog explores the transformative potential of postbiotics in skin health, drawing from current scientific insights and key findings from a comprehensive review published in Biomedicines. The review highlights the importance of the skin microbiome, its dysfunction in disease, and how postbiotics are redefining dermatological care globally.


Understanding the Skin Microbiome: The First Line of Defense

The human skin is more than just a physical barrier—it’s a living, breathing ecosystem inhabited by trillions of microorganisms. These microbes are not just passive bystanders; they actively contribute to immune function, barrier maintenance, hydration, pH regulation, and protection from harmful pathogens.

However, when this ecosystem is disrupted—a state known as dysbiosis—the results can be severe. Common skin diseases such as acne, eczema, psoriasis, and rosacea have been directly linked to imbalances in microbial communities.

For example:

  • Acne involves overgrowth of Cutibacterium acnes in oily skin environments.
  • Eczema is associated with a decline in Staphylococcus epidermidis and a surge in Staphylococcus aureus, which disrupts immune homeostasis.
  • Psoriasis features an enrichment of pro-inflammatory bacteria and loss of beneficial Actinobacteria.

What Are Postbiotics and Why Are They Important?

Unlike probiotics (live microorganisms) or prebiotics (substrates that promote beneficial microbes), postbiotics are non-living microbial products—such as cell wall fragments, enzymes, peptides, and short-chain fatty acids (SCFAs)—that offer therapeutic effects.

Key advantages include:

  • Enhanced safety (no risk of microbial overgrowth or infection)
  • Stability in skincare formulations
  • Targeted action on inflammation, hydration, and skin barrier repair
  • Immediate functional benefits without requiring colonization

Postbiotics are rapidly emerging as a global solution for skin health, especially in populations with sensitive or compromised skin barriers where probiotics may pose risks.


Key Insights from the Literature: Postbiotics in Action

The Biomedicines review highlights several breakthrough insights:

1. Postbiotics Improve Skin Barrier Function

Postbiotics strengthen the skin’s protective outer layer by increasing tight junction proteins and ceramide production. These effects are especially critical for dry or sensitive skin types where barrier function is compromised.

For instance, Lactobacillus plantarum postbiotics have shown UV-protective and anti-aging effects by reducing melanin content and improving elasticity.

2. Anti-Inflammatory and Antimicrobial Effects

Certain postbiotics derived from Staphylococcus epidermidis and Lactobacillus species produce antimicrobial peptides (AMPs) like phenol-soluble modulins, which inhibit harmful bacteria such as Staphylococcus aureus—a key player in eczema and other inflammatory skin conditions.

3. Wound Healing and Skin Regeneration

Postbiotics support wound healing by promoting collagen synthesis, angiogenesis (new blood vessel formation), and epithelial cell proliferation. Studies on Lactobacillus reuteri-derived postbiotics have shown enhanced wound closure and improved skin architecture.

4. Photoprotection and Anti-Pigmentation

Postbiotics like malassezin (from Malassezia furfur) and pityriacitrin offer UV-protective benefits and reduce hyperpigmentation. These compounds are now used in commercial skin-whitening and sun-care products due to their selective effects on melanocytes.

5. Efficacy in Acne and Atopic Dermatitis

Postbiotics like LactoSporin (from Bacillus coagulans) have been shown in clinical studies to reduce sebum, pimples, and redness in acne-prone individuals. In atopic dermatitis, oral postbiotics have demonstrated regulation of Th1/Th2 immune balance and reduction in pro-inflammatory markers.


Global Health and Commercial Impact

Skin diseases are a global health crisis, affecting over 1.9 billion people annually and costing the U.S. healthcare system alone more than $75 billion per year. The need for safer, more effective, and accessible treatments has never been greater.

Here’s where postbiotics shine:

  • Formulation flexibility: They can be integrated into creams, gels, cleansers, and serums.
  • Cross-border usability: Stable under extreme temperatures and humidity, making them ideal for global distribution.
  • Compliance and safety: Reduced allergenic or immunogenic risks, increasing consumer acceptance.
  • Cost-effectiveness: Scalable production and long shelf life offer advantages over live probiotics.

As more consumers seek microbiome-friendly skincare, the demand for postbiotic-based formulations is rapidly accelerating. From cosmeceuticals to prescription dermatology, postbiotics are finding applications across preventive, therapeutic, and aesthetic domains.


Diverse Skin Types, Diverse Microbiomes

Another important takeaway from the review is the individualized nature of the skin microbiome. Variations in sebum production, melanin content, hydration levels, and sweat influence the microbiota across:

  • Dry vs. Oily skin: Different bacterial and fungal species dominate, affecting susceptibility to acne or dermatitis.
  • Light vs. Dark skin: Melanin influences microbiome composition and microbial metabolism.
  • Rough vs. Smooth skin: Rough areas often host less microbial diversity and more inflammatory markers.
  • Male vs. Female skin: Hormonal differences alter microbial communities and response to treatments.

Understanding these nuances helps researchers and skincare companies develop personalized postbiotic solutions for different skin types, conditions, and demographics.


Future Outlook: Challenges and Opportunities

Despite growing enthusiasm, several challenges remain:

  • Mechanistic clarity: While the benefits of postbiotics are evident, the exact pathways through which they influence immune responses and microbial balance need more investigation.
  • Standardization: Ensuring consistency in postbiotic composition, concentration, and bioavailability across formulations is critical.
  • Regulatory approval: Clear guidelines on claims, safety testing, and clinical validation are still evolving globally.

Nevertheless, ongoing research and innovation continue to push boundaries. With more companies investing in microbiome science and postbiotic R&D, the future of skincare is undeniably shifting towards microbiome-based dermatology.


Conclusion: A Postbiotic Revolution in Skin Health

The evidence is compelling: postbiotics are not just a trend—they are a transformative leap in skin science. From acne and eczema to pigmentation disorders and sunburn, these microbial metabolites offer safer, smarter, and more sustainable solutions.

In a world increasingly conscious of health, hygiene, and holistic wellness, postbiotics hold the key to restoring the skin’s natural balance while aligning with consumer demands for clean, effective, and microbiome-friendly products.

As science advances, postbiotics are poised to become a global standard in both therapeutic dermatology and everyday skincare. Now is the time for researchers, clinicians, and brands to embrace this revolution—and lead the way in shaping the microbiome era of skin health.


Author’s Note:
This blog is inspired by the extensive review article The Role of Postbiotics in Skin Health: A Microbiome-Based Perspective on Dermatology from Biomedicines. It is a must-read for scientists, dermatologists, and skincare innovators seeking to understand the cutting edge of microbiome therapeutics.

If you’d like to explore research collaborations or postbiotic innovations for skin, feel free to connect with MusB Research or send us an email: info@musbresearch.com.

MusB Research Launches New Website to Expand State-of-the-Art Research Services

Tampa, FL – MusB Research, a pioneering company in the field of nutraceutical, diet, and pharmaceutical research, is proud to announce the launch of its new website. With over 20 years of research experience, MusB Research is dedicated to providing state-of-the-art services to clients looking to substantiate their product claims in areas such as microbiome health, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity, diabetes, and bioavailability.

The new website offers a comprehensive overview of MusB Research’s services, showcasing their expertise in developing innovative solutions for the nutraceutical, dietary, and pharmaceutical industries. The website’s user-friendly design ensures easy navigation for clients seeking detailed information about how MusB Research can help them achieve market dominance through scientifically validated evidence.

“We are excited to launch our new website and expand our reach to a broader audience,” said Dr. Shalini Jain, Founder and CEO of MusB Research. “Our mission is to support our clients with cutting-edge research that substantiates their product claims and drives innovation in the competitive health market. Our new online platform reflects our commitment to excellence and our dedication to helping clients succeed.”

MusB Research’s advanced models and assays provide valuable insights into the efficacy and safety of products, enabling clients to develop evidence-based products that stand out in the market. With a focus on areas such as aging, microbiome health, and metabolic diseases, MusB Research leverages its extensive expertise to deliver reliable and impactful results.

Visit the new MusB Research website at www.musbresearch.com to learn more about their services and how they can help you substantiate your product claims with robust scientific data. Contact MusB Research today to get started on your project and take your products to the next level.

MusB Research Launches to Offer Cutting-Edge Research Services for Nutraceutical, Diet, and Pharma Companies

Tampa, FL – [Date] – MusB Research, a pioneering venture in scientific research, is excited to announce its official launch. The company is set to provide state-of-the-art research services aimed at helping nutraceutical, dietary, and pharmaceutical companies develop substantiation for their products.

MusB Research leverages years of expertise in the fields of microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability. The company’s comprehensive services include advanced assays, animal models, and clinical studies designed to validate product claims with robust scientific evidence.

“At MusB Research, our mission is to drive innovation and success for our clients by offering unparalleled research services,” said Dr. Hariom Yadav, founder and CEO of MusB Research. “We understand the critical importance of scientifically validated evidence in today’s competitive market. Our cutting-edge research capabilities will enable our clients to substantiate their product claims effectively and stand out in the marketplace.”

MusB Research’s offerings include:

  • Microbiome and Gut Health: Advanced testing and analysis to understand the impact of products on gut microbiota and overall gut health.
  • Probiotics Development: Specialized assays to develop and validate the efficacy of probiotic strains.
  • Aging and Longevity: Research focused on anti-aging properties and interventions to promote healthy aging.
  • Leaky Gut and Toxicity: Comprehensive studies to assess product safety and efficacy in preventing or mitigating leaky gut syndrome and other toxicological concerns.
  • Brain and Muscle Health: In-depth analysis of product effects on cognitive function, neuroprotection, and muscle health.
  • Obesity and Diabetes: Evaluation of compounds for their potential to manage weight and improve metabolic health.
  • Bioavailability: Studies to determine the absorption and efficacy of bioactive compounds in various products.

MusB Research is committed to providing clients with detailed reporting, future recommendations, and consulting services to maximize their product’s market potential. By partnering with MusB Research, companies can ensure their products are backed by rigorous scientific data, enhancing credibility and consumer trust.

For more information about MusB Research and its services, please visit [website link] or contact [contact information].

Media Contact:

Dr. Hariom Yadav
Founder and CEO, MusB Research
[Email Address]
[Phone Number]

About MusB Research: MusB Research is a leading scientific research company specializing in providing comprehensive research services for nutraceutical, dietary, and pharmaceutical companies. With a focus on microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability, MusB Research aims to drive innovation and success through scientifically validated evidence.

MusB Research Enters Market with Over 20 Years of Expertise to Cater to a Specialized Niche in Nutraceutical, Diet, and Pharma Industries

Tampa, FL – [Date] – MusB Research is proud to announce its launch, bringing over 20 years of extensive research experience to the nutraceutical, dietary, and pharmaceutical industries. The company aims to cater to a specialized niche, offering cutting-edge research services to help clients substantiate their product claims and gain a competitive edge in the market.

MusB Research is founded on a legacy of scientific excellence, focusing on areas such as microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability. The company’s state-of-the-art research capabilities are designed to provide robust, evidence-based validation for a wide range of products.

“Our team at MusB Research has a deep understanding of the scientific intricacies required to support the claims of nutraceutical, dietary, and pharmaceutical products,” said Dr. Hariom Yadav, founder and CEO of MusB Research. “With over two decades of research experience, we are uniquely positioned to offer unparalleled services that help our clients navigate the complexities of product substantiation and succeed in a competitive market.”

Key Services Offered by MusB Research:

  • Microbiome and Gut Health: Advanced testing and analysis to explore the effects of products on gut microbiota and overall gut health.
  • Probiotics Development: Expertise in developing and validating the efficacy of probiotic strains.
  • Aging and Longevity: Focused research on anti-aging properties and interventions for promoting healthy aging.
  • Leaky Gut and Toxicity: Comprehensive assessments to determine product safety and efficacy in addressing leaky gut syndrome and toxicological concerns.
  • Brain and Muscle Health: In-depth analysis of the impact of products on cognitive function, neuroprotection, and muscle health.
  • Obesity and Diabetes: Evaluation of compounds for their potential to manage weight and improve metabolic health.
  • Bioavailability: Studies to assess the absorption and efficacy of bioactive compounds in various products.

MusB Research’s commitment to scientific rigor and innovation is reflected in its detailed reporting, future recommendations, and consulting services, all aimed at maximizing the market potential of client products. By partnering with MusB Research, companies can ensure their products are backed by robust scientific data, enhancing credibility and consumer trust.

For more information about MusB Research and its specialized services, please visit [website link] or contact [contact information].

Media Contact:

Dr. Hariom Yadav
Founder and CEO, MusB Research
[Email Address]
[Phone Number]

About MusB Research: MusB Research is a pioneering scientific research company dedicated to providing comprehensive research services for the nutraceutical, dietary, and pharmaceutical industries. With over 20 years of research experience, MusB Research specializes in microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability. The company’s mission is to drive innovation and success through scientifically validated evidence, helping clients substantiate their product claims and achieve market dominance.

Events

Stay informed about the latest news and updates from MusB Research. From groundbreaking discoveries to exciting collaborations, we keep you updated on all the happenings within our organization.

PublicationsA mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut

Abstract

Objective Ample evidence exists for the role of abnormal gut microbiota composition and increased gut permeability (‘leaky gut’) in chronic inflammation that commonly co-occurs in the gut in both obesity and diabetes, yet the detailed mechanisms involved in this process have remained elusive.

Design In this study, we substantiate the causal role of the gut microbiota by use of faecal conditioned media along with faecal microbiota transplantation. Using untargeted and comprehensive approaches, we discovered the mechanism by which the obese microbiota instigates gut permeability, inflammation and abnormalities in glucose metabolism.

Results We demonstrated that the reduced capacity of the microbiota from both obese mice and humans to metabolise ethanolamine results in ethanolamine accumulation in the gut, accounting for induction of intestinal permeability. Elevated ethanolamine increased the expression of microRNA-miR-101a-3p by enhancing ARID3a binding on the miR promoter. Increased miR-101a-3p decreased the stability of zona occludens-1 (Zo1) mRNA, which in turn, weakened intestinal barriers and induced gut permeability, inflammation and abnormalities in glucose metabolism. Importantly, restoring ethanolamine-metabolising activity in gut microbiota using a novel probiotic therapy reduced elevated gut permeability, inflammation and abnormalities in glucose metabolism by correcting the ARID3a/miR-101a/Zo1 axis.

Conclusion Overall, we discovered that the reduced capacity of obese microbiota to metabolise ethanolamine instigates gut permeability, inflammation and glucose metabolic dysfunctions, and restoring ethanolamine-metabolising capacity by a novel probiotic therapy reverses these abnormalities.

modal close image